NCT07459010

Brief Summary

Objective: (1) To examine the feasibility of proceeding to a future definitive RCT of ACT in Hong Kong Chinese fathers rearing children with special needs. (2) To calculate the effect sizes of the intervention on fathers' psychological flexibility, shame, guilt, and quality of life (QoL) at the 6-month follow-up. (3) To calculate the potential efficacy of the intervention. Methods: A 2-arm feasibility randomised controlled trail will be conducted on 50 fathers of children with special needs. 25 participants will be allocated into the intervention group to attend 6 weekly 45-60 minute sessions of ACT with VR. 25 participants will be allocated to the control group receiving 6 weekly 45-60 minute sessions of health talks and simple social support. Outcome and measurement: Primary outcomes are screening rate, eligibility rate, consent rate, randomization rate, attendance rate, adherence rate, retention rate, completion rate, missing data, and adverse events. Secondary outcomes are the effect sizes and preliminary efficacy of the intervention on psychological flexibility, shame, guilt, depressive symptoms, and QoL at T4. Both groups will be required to fill in a set of questionnaires at the start of intervention (T1), post-intervention (T2), 3 (T3), and 6 months (T4) after the end of intervention. They will also be invited to join semi-structure interviews at T2. Data analysis: Descriptive statistics, mixed between-within-participants analysis of variance, and content analysis will be used.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
26mo left

Started Jun 2026

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress7%
Jun 2026Oct 2028

First Submitted

Initial submission to the registry

February 27, 2026

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 9, 2026

Completed
3 months until next milestone

Study Start

First participant enrolled

June 1, 2026

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2028

Last Updated

March 9, 2026

Status Verified

March 1, 2026

Enrollment Period

2.3 years

First QC Date

February 27, 2026

Last Update Submit

March 4, 2026

Conditions

Keywords

mental healthAcceptance and Commitment TherapyFatherchild developmental disabilitiesVirtual realitypsychological flexibility

Outcome Measures

Primary Outcomes (10)

  • Screening rate

    Calculated as the number of fathers of children with special needs screened at participated NGOs divided by number of fathers with special needs at participated NGOs during the recruitment period.

    During the recruitment period (up to 10 months)

  • Eligibility rate

    Calculated by dividing the number of fathers who are eligible by the number who are screened.

    During the recruitment period (up to 10 months)

  • Consent rate

    Calculated by dividing the number of fathers who consent to join the study by the number who are eligible.

    During the recruitment period (up to 10 months)

  • Randomization rate

    Calculated by dividing the number of fathers who are randomized into intervention and control groups by those who provide consent.

    T1 (start of intervention)

  • Attendance rate

    Calculated by dividing the number of fathers who complete the intervention by those who are randomized.

    T2 (post-intervention at 6 weeks)

  • Retention rate

    Calculated by dividing the number of fathers who remain in the study by those who are randomized. Retention rates for the intervention and control groups will be calculated at each follow-up.

    T2 (post-intervention at 6 weeks), T3 (3 months after intervention), T4 (6 months after intervention)

  • Adherence rate

    Calculated by dividing the number of fathers who follow the intervention protocol by those who are randomized.

    T2 (post-intervention at 6 weeks)

  • Complete rate

    Calculated by dividing the number of fathers who returned questionnaires by the number of questionnaires distributed. This will be calculated by groups at baseline and each follow-up.

    T1 (start of intervention) , T2 (post-intervention at 6 weeks), T3 (3 months after intervention), T4 (6 months after intervention)

  • Proportion of missing data

    Calculated as the percentage of missing values in the dataset. Unknown or blank values will be considered missing values.

    T4 (6 months after intervention)

  • Adverse events

    Adverse events are defined as unfavorable and unintended events that are not present at baseline, or appear to have worsened during the study.

    T4 (6 months after intervention)

Secondary Outcomes (5)

  • Psychological flexibility

    T1 (at the start of intervention), T4 (at 6 months after the end of intervention)

  • Shame

    T1 (at the start of intervention), T4 (at 6 months after the end of intervention)

  • Guilt

    T1 (at the start of intervention), T4 (at 6 months after the end of intervention)

  • Depressive symptoms

    T1 (at the start of intervention), T4 (at 6 months after the end of intervention)

  • Quality of life (QoL)

    T1 (at the start of intervention), T4 (at 6 months after the end of intervention)

Study Arms (2)

VR-based ACT

EXPERIMENTAL

VR-based ACT for fathers of children with special needs

Behavioral: VR-based ACT

Control

PLACEBO COMPARATOR

health talks and simple social support

Behavioral: Health Talks and Simple Social Support

Interventions

VR-based ACTBEHAVIORAL

Participants in the intervention group will be invited to attend 6 weekly sessions of ACT with VR. Each session will last approximately 45-60 minutes.

VR-based ACT

Participants in the control group will receive 6 weekly sessions of health talks and simple social support to mimic the time and attention spent on the intervention group.

Control

Eligibility Criteria

Sexmale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • (1) who are the biological fathers of children aged 2 to 12 years
  • (2) with a child having a formal diagnosis of a developmental disability, including autism spectrum disorder, attention deficit/hyperactivity disorder, intellectual disability, or related neurodevelopmental conditions
  • (3) who are able to speak Cantonese and read Chinese

You may not qualify if:

  • (1) who are currently undergoing psychotherapies
  • (2) with physical or cognitive impairment and learning problems as identified from NGO or related medical records
  • (3) who exhibit a high risk of serious mental illnesses screened using the Kessler Psychological Distress Scale , with a score of ≥13

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Developmental DisabilitiesPsychological Well-Being

Condition Hierarchy (Ancestors)

Neurodevelopmental DisordersMental DisordersPersonal SatisfactionBehavior

Central Study Contacts

Ka Wai Katherine LAM, Doctor of Philosophy

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

February 27, 2026

First Posted

March 9, 2026

Study Start

June 1, 2026

Primary Completion (Estimated)

October 1, 2028

Study Completion (Estimated)

October 1, 2028

Last Updated

March 9, 2026

Record last verified: 2026-03